Dr. Mohamed D. Mahmoud
/ Sub-Investigator
Dr. Mahmoud serves as a Sub-Investigator at Integrity Advanced Therapeutics (IAT), contributing his clinical expertise, precision, and patient-first mindset to the successful execution of a wide range of clinical studies.
As a practicing physician with a strong background in gastroenterology and hepatology, Dr. Mahmoud plays a vital role in ensuring that research protocols are rigorously followed, patient outcomes are prioritized, and data integrity is maintained.
Dr. Mahmoud’s clinical research work supports the advancement of novel therapies in areas such as Inflammatory Bowel Disease (IBD), Non-Alcoholic Fatty Liver Disease (NAFLD), liver fibrosis, and functional gastrointestinal disorders.
His collaborative approach and dedication to excellence strengthen IAT’s commitment to ethical, high-impact research.
Skills & Qualifications
- Clinical Gastroenterology and Hepatology
- Clinical Trial Protocol Execution and Patient Safety Monitoring
- Inflammatory Bowel Disease (IBD) Research
- Liver Disease Research (NAFLD, Hepatitis, Cirrhosis)
- Clinical Assessments and Adverse Event Management
- Research Compliance and Good Clinical Practice (GCP)
Professional Experience:
- 10+ years of clinical practice and clinical research collaboration
- Sub-Investigator for multiple Phase II–IV clinical trials across gastroenterology and hepatology
- Expert in patient assessments, monitoring, and protocol-driven clinical trial execution
- Skilled at maintaining regulatory standards and ensuring clinical trial integrity
Contributions to Research
- Conducts patient screening, enrollment, and monitoring
- Ensures accurate clinical data collection and reporting
- Supports site management activities and continuous study quality improvement
- Inflammatory Bowel Disease (IBD)
- Non-Alcoholic Fatty Liver Disease (NAFLD)
- Advanced Endoscopy and Diagnostics
- Hepatitis B & C Management
- Clinical Trials in Hepatology and Gastroenterology